Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Paradigm Diagnostics
445 N. 5th Street, Suite 300
Phoenix, AZ 85004
Phone: 602-850-7000
http://www.pdx-inc.com/

Paradigm is a private molecular information corporation established to bring cutting-edge diagnostics to cancer patients and industry by providing information about the genomic makeup of the patient's cancer and potential therapies based on the specific characterization of the patient's tumor that can impact the patient's course of treatment. Paradigm's Next-Generation Sequencing based diagnostic test PCDx provides oncologists and patients with more precise information about the specific cancer pathways in the patient and associations between the pathways and the specific drugs available that can affect the cancer to allow for more effective decision-making. The test is driven by supporting data and literature and provides more choices for patient care than currently available on the market.

Key Contact
NameTitleE-Mail
David MalleryCEOdmallery@paradigmdx.org


Funding Events
DateAmountTypeInvestors
11/16/16$7,000,000Series B Mesa Verde Venture Partners
05/15/19$8,000,000Series B Extension BlueStone Venture Partners
Gore Range Ventures
Mesa Verde Venture Partners
New Science Ventures
OSF Healthcare
Prairie Ventures
Tech Coast Angels
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.